Global Cord Blood Statistics
Total Valuation
Global Cord Blood has a market cap or net worth of 167.39 million.
| Market Cap | 167.39M |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Friday, November 22, 2024.
| Earnings Date | Nov 22, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Global Cord Blood has 133.91 million shares outstanding.
| Shares Outstanding | 133.91M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.36% |
| Float | 120.33M |
Valuation Ratios
The trailing PE ratio is 1.92.
| PE Ratio | 1.92 |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| PB Ratio | 0.20 |
| P/FCF Ratio | 1.79 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.73, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.73 |
| Quick Ratio | 10.64 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.99% and return on invested capital (ROIC) is 8.21%.
| Return on Equity (ROE) | 10.99% |
| Return on Assets (ROA) | 4.63% |
| Return on Capital (ROIC) | 8.21% |
| Revenue Per Employee | 163,145 |
| Profits Per Employee | 65,752 |
| Employee Count | 1,202 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 4.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.25 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.50 |
| 200-Day Moving Average | 1.40 |
| Relative Strength Index (RSI) | 29.12 |
| Average Volume (20 Days) | 709 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.44 |
Income Statement
In the last 12 months, Global Cord Blood had revenue of 196.10 million and earned 79.03 million in profits. Earnings per share was 0.65.
| Revenue | 196.10M |
| Gross Profit | 167.19M |
| Operating Income | 96.04M |
| Pretax Income | 99.03M |
| Net Income | 79.03M |
| EBITDA | 103.60M |
| EBIT | 96.04M |
| Earnings Per Share (EPS) | 0.65 |
Balance Sheet
The company has 1.05 billion in cash and 23,186 in debt, giving a net cash position of 1.05 billion or 7.85 per share.
| Cash & Cash Equivalents | 1.05B |
| Total Debt | 23,186 |
| Net Cash | 1.05B |
| Net Cash Per Share | 7.85 |
| Equity (Book Value) | 770.51M |
| Book Value Per Share | 6.33 |
| Working Capital | 991.88M |
Cash Flow
In the last 12 months, operating cash flow was 96.79 million and capital expenditures -3.12 million, giving a free cash flow of 93.66 million.
| Operating Cash Flow | 96.79M |
| Capital Expenditures | -3.12M |
| Free Cash Flow | 93.66M |
| FCF Per Share | 0.70 |
Margins
Gross margin is 85.26%, with operating and profit margins of 48.97% and 40.30%.
| Gross Margin | 85.26% |
| Operating Margin | 48.97% |
| Pretax Margin | 50.50% |
| Profit Margin | 40.30% |
| EBITDA Margin | 52.83% |
| EBIT Margin | 48.97% |
| FCF Margin | 47.76% |
Dividends & Yields
Global Cord Blood does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Global Cord Blood has an Altman Z-Score of 2.33. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.33 |
| Piotroski F-Score | n/a |